• SENSEX 73,749.37
    503.34 (+0.69%)
  • BANKNIFTY 54,267.40
    292.50 (+0.54%)
  • Jio Platforms
    1,490.00 1,423.80(%)
  • The Bombay Burmah
    1,203.00 2,050.25(%)
  • NSE
    1,795.00 1,878.00(%)
  • Aeroflex
    569.95 613.50(%)
  • Pidilite Inds.
    1,344.00 1,259.45(%)
  • Cholaman.Inv.&Fn
    1,589.95 1,952.00(%)
  • Bajaj Finance
    931.00 1,177.60(%)
  • Reliance Industries
    1,182.00 1,611.20(%)
  • M & M Fin. Serv.
    256.60 253.30(%)
  • Max Healthcare
    865.95 1,196.50(%)
  • Tube Investments
    2,098.60 2,006.00(%)
  • JSW Dulux
    285.65 374.67(%)
  • Birlasoft Ltd
    343.75 473.75(%)
  • Dalmia BharatLtd
    1,403.50 1,464.85(%)
  • Acutaas Chemical
    4,000.00 3,977.00(%)
  • Tonbo Imaging
    1,175.75 1,013.95(%)
  • Moneyview
    52.44 65.43(%)
  • Apollo Hospitals
    8,239.00 9,326.80(%)
  • Adani Ports
    1,839.80 1,891.80(%)
  • DLF
    674.90 786.40(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Lactose (India) Ltd Pharmaceuticals - Indian - Bulk Drugs

  • Toshniwal
  • BSE Code : 2283.0
  • ISIN : INE058I01013
107.00 5 (5.31%)
  • As on 29 Oct 2026 (EOD)

  • Today’s Low

    100.15

  • Today’s High

    120.00

  • Open

    101.00

  • Perv Close

    101.60

  • 52W Low

    76.01

  • 52W High

    136.45

Key Indicators

  • P/E(TTM)

    19.45

  • Mar.Cap (₹Cr.)

    134.70

  • Div & Yield %

    0.00

  • Book Value(₹)

    46.28

  • Debt-Equity Ratio

    5.31

  • AGM Date

    28-Oct-2026

  • EPS

    5.50

  • P/E Ratio

    19.45

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    134.70

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    12.59

  • BV (₹)

    46.30

  • Sales( ₹ in Cr.)

    163.29

  • NP (in Cr.)

    6.06

  • NP Var(%)

    18.0

  • Div%

    0.0

  • CPS (₹)

    9.40

  • EPS (₹)

    4.80

  • Traded Value (₹ in Lakhs)

    134.70

  • 52 Week High

    136.45

  • 52 Week Low

    76.01

  • Price BSE

    107.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    134.70

  • P/C Ratio

    11.40

  • P/E Ratio

    22.20

  • Price Vs.BV

    4.80

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 163.29 116.40 113.89 65.80 45.94 34.96
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 163.29 116.40 113.89 65.80 45.94 34.96
Other Income 1.07 1.45 1.12 0.72 0.58 0.31
Stock Adjustments -6.77 8.14 -2.70 11.31 -0.40 -0.52
Total Income 157.59 125.99 112.31 77.83 46.12 34.75
EXPENDITURE :            
Raw Materials 87.52 60.51 48.86 35.50 7.18 4.65
Power and Fuel Cost 11.02 10.28 9.69 7.09 6.89 5.84
Employee Cost 12.17 10.50 8.72 6.57 12.25 10.63
Other Manufacturing Expenses 14.52 14.56 14.34 10.11 1.98 1.64
Selling and Administration Expenses 10.44 9.64 8.65 4.28 2.89 2.80
Miscellaneous Expenses 2.48 2.09 1.92 2.18 2.08 2.65
Employee Benefit Expenses 12.17 10.50 8.72 6.57 12.25 10.63
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 138.15 107.58 92.18 65.74 33.28 28.22
Operating Profit 19.45 18.41 20.13 12.10 12.85 6.54
Interest 5.09 6.10 5.25 5.95 5.12 5.45
Gross Profit 14.36 12.31 14.88 6.15 7.73 1.09
Depreciation 5.74 5.39 5.22 4.69 4.56 4.36
Profit Before Tax 8.62 6.92 9.66 1.46 3.17 -3.27
Current Tax 1.22 1.32 1.57 0.18 0.57 0.05
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 1.34 0.44 1.31 0.08 0.15 -0.84
Reported Net Profit 6.06 5.16 6.79 1.21 2.45 -2.48
Extraordinary Items 0.00 0.04 0.01 0.02 0.03 0.00
Adjusted Net Profit 6.06 5.12 6.78 1.19 2.42 -2.48
Adjustment below Net Profit -0.01 -0.05 -0.25 0.00 0.00 0.00
P & L Balance brought forward 25.79 20.67 14.14 12.84 10.39 12.87
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down 31.84 25.79 20.67 14.05 12.84 10.39
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 4.82 4.10 5.39 0.96 1.95 -2.17
Earnings Per Share(Adj)-Unit Curr 4.82 4.10 5.39 0.96 1.95 -2.17
Book Value 46.28 41.48 37.41 32.22 31.21 30.15
Book Value(Adj)-Unit Curr 46.28 41.48 37.41 32.22 31.21 30.15

Shareholding Pattern

  • Promoter Group

    53.65%

  • Public Share Holding

    46.35%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 5,428,242 43.12 5,428,242 5
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 1,325,184 10.53 1,325,184 1
Others 0 0.00 0 0
Sub Total 6,753,426 53.65 6,753,426 6
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 77,920 0.62 0 4
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 77,920 0.62 0 4
2] Non Institution
Bodies Corporate 754,954 6.00 737,907 61
Clearing Members 1,898 0.02 1,898 5
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 37,139 0.30 37,139 65
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 102,124 0.81 102,124 92
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 755,134 6.00 755,134 20
Individuals holding nominal share capital up to Rs. 1 lakh 4,106,405 32.62 2,018,319 16,229
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 5,757,654 45.74 3,652,521 16,472
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 12,589,000 100.00 10,405,947 16,482

Company Background

Lactose (India) LtdPharmaceuticals - Indian - Bulk Drugs

  • Lactose (India) Ltd
  • BSE Code : 2283.0
  • ISIN : INE058I01013

  • Incorporation Year

    1991

  • Registered Office

    Survey No 6
    Village Poicha (Rania) Savli, Vadodara,
    Gujarat-391780

  • Telephone

    91-02667-244308/244729

  • FAX

    91-02667-840397

  • Chairman

    Atul Maheshwari

  • Managing Director

    Atul Maheshwari

  • Company Secretary

    Ritesh Pandey

  • Auditor

    DMKH & Co

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    Bigshare Services Pvt Ltd
    Office No S6-2,
    Pinnacle Busine.Park,Mahakali Caves Road
    Mumbai - Mumbai - 400093

Lactose (India) Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Lactose (India) 107.00 164.36 163.29 19.45 11.14
Abbott India 26,278.90 7,217.19 6,929.05 34.58 43.78
Astrazeneca Phar 6,234.70 2,304.07 2,275.58 91.89 27.86
Glaxosmi. Pharma 2,496.65 3,932.76 3,790.20 39.88 58.17
Novartis India 1,805.95 393.10 354.33 45.60 15.94
Cipla 1,360.00 20,102.60 18,979.95 41.45 13.88
Bliss GVS Pharma 650.05 773.53 729.81 60.41 12.51
Amrutanjan Healt 491.10 520.13 502.55 26.30 24.16
Fermenta Biotec. 443.85 474.15 450.25 20.72 18.77
Guj. Themis Bio. 355.25 168.25 165.82 94.99 18.05
Ambalal Sarabhai 35.73 19.52 3.94 66.17 6.77